Journals / The Journal of Pediatric Research / 2017 / Cilt: 4 - Sayı: 3

A New Problem of Adolescents: "Bonsai"

Ergenlerde Yeni Bir Sorun: "Bonzai"

Pages
163–166
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, three adolescent males are reported, who were admitted to the emergency department with severe chest pain and significantly higher cardiac enzymes, and who claimed to have used "bonsai".

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Synthetic cannabinoids have been increasingly used by adolescents in the recent years.
📊
Key Findings & Data:In our country, synthetic cannabinoids are known as "bonsai".
💡
Conclusion & Impact:In this article, three adolescent males are reported, who were admitted to the emergency department with severe chest pain and significantly higher cardiac enzymes, and who claimed to have used "bonsai".
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Synthetic cannabinoids have been increasingly used by adolescents in the recent years. In our country, synthetic cannabinoids are known as "bonsai". They may cause neuropsychiatric effects such as psychosis, agitation, ataxia, convulsion, hallucinations, and may also cause cardiovascular symptoms such as tachycardia, systolic hypertension, postural hypotension and chest pain. In this article, three adolescent males are reported, who were admitted to the emergency department with severe chest pain and significantly higher cardiac enzymes, and who claimed to have used "bonsai".

Özet

Sentetik kannabinoidlerin son yıllarda ergenlerde kullanımı artmaktadır. Ülkemizde "bonzai" olarak bilinmektedirler. Psikoz, ajitasyon, ataksi, konvülsiyon, halüsinasyon gibi nöropsikiyatrik etkilere neden olabildiği gibi; taşikardi, sistolik hipertansiyon, postural hipotansiyon ve göğüs ağrısı gibi kardiyovasküler semptomlara da yol açabilmektedir. Bu makalede; şiddetli göğüs ağrısı ve kardiyak enzim yüksekliği ile acil servise başvuran ve "bonzai" kullandıklarını ifade eden üç erkek ergen sunuldu.

🔖

Cite This Article

GÜL, Ö., GÜRSES, D., ÖZDEMİR, E., YILDIZ, F. (2017). A New Problem of Adolescents: "Bonsai". The Journal of Pediatric Research, Cilt: 4 - Sayı: 3, 163–166. https://ajindex.com/articles/362818

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Evren C, Bozkurt M. Synthetic Cannabinoids: Crisis of The Decade. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 2013;26:1-11
  2. Atik Ugan S, Dedeoğlu R, Varol F, Çam H, Eroğlu AG, Saltık L. "Bonzai" kullanımına bağlı kalp ve damar sistemi yan etkileri: İki olgu sunumu. Türk Ped Arş 2015;50:61-4
  3. Alp H, Alp E. Çocuk kardiyoloji kliniğine göğüs ağrısı nedeniyle başvuran çocukların etiyolojik değerlendirilmesi. J Pediatr Res 2014;1:80-3
  4. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660
  5. Ayhan H, Aslan AN, Süygün H, Durmaz T. Bonzai kullanımı sonrası ortaya çıkan akut miyokart enfarktüsü. Türk Kardiyol Dern Arş 2014;42:560-3
  6. Gurdal F, Asirdizer M, Aker RG, et al. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. J Forensic Leg Med 2013;20:667-72
  7. Monitoring the future study: Trends in prevalence of various drugs. http://www.drugabuse.gov/trends-statistics/ monitoring-future/monitoring-future-study-trends-inprevalence-various-drugs (Erişim: 14 Ocak 2016)
  8. Gurney SM Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs. Forensic Sci Rev 2014;26:53-78
  9. Alikaşifoğlu M, Ercan O. Ergenlerde Madde Kullanımı. Turkiye Klinikleri J Pediatr Sci 2006;2:76-83
  10. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012;60:435-8.